Welcome to our dedicated page for Airsculpt Technologies SEC filings (Ticker: AIRS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AirSculpt Technologies, Inc. filings document the regulatory record of a public medical aesthetics company that provides premium body contouring procedures. Its 8-K reports cover operating and financial results, preliminary updates, non-GAAP financial measures, reconciliations, debt and capital-structure disclosures, material agreements, and governance events.
Proxy materials describe annual meeting matters, director elections, shareholder voting items, board structure, and related governance disclosures. Other filings include late-filing notices tied to annual report timing, amendments correcting non-GAAP presentation, and emerging growth company status under SEC reporting rules.
Airsculpt Technologies, Inc. ten percent owner Jorey Chernett purchased common stock in the open market. He bought 77,702 shares at a weighted average price of $2.64 per share, with individual trade prices ranging from $2.49 to $2.70. Following these purchases, he directly owns 6,753,761 shares of common stock.
Airsculpt Technologies, Inc. filed an initial ownership report for its General Counsel, Brent R. Wadman, on Form 3. The filing identifies him as an officer of the company but does not list any reportable transactions, derivative positions, or specific share holdings in this disclosure.
Airsculpt Technologies, Inc. ten percent owner Jorey Chernett reported an open-market purchase of 83,000 shares of Common Stock at a weighted average price of $2.56 per share on March 17, 2026. Following this trade, Chernett directly owns 6,676,059 shares.
The filing notes the price is a weighted average, with individual purchase prices ranging from $2.43 to $2.70 per share. It also corrects a prior Form 4, which had under‑reported Chernett’s beneficial ownership by 1,000 shares due to a clerical error.
Airsculpt Technologies, Inc. insider Jorey Chernett purchased 105,848 shares of Common Stock in an open-market transaction. The weighted average purchase price was $2.43 per share, with individual trades executed between $1.93 and $2.79 per share. After this transaction, Chernett directly owns 6,592,059 shares.
Airsculpt Technologies, Inc. receives an amended Schedule 13G showing Parian Ultreia beneficially owns 5,988,585 shares of AirSculpt Technologies, representing 9.59% of the class as reported in the filing. The filing states sole voting and dispositive power over those 5,988,585 shares.
AirSculpt Technologies, Inc. has notified the SEC that it is unable, without unreasonable effort or expense, to file its Form 10-K for the fiscal year ended December 31, 2025 by the March 16, 2026 deadline due to the classification of inter-company transactions and balances. The company anticipates filing within the fifteen-day grace period provided by Rule 12b-25, but states there is no assurance on timing.
AirSculpt Technologies plans to file a Form 12b-25 to delay its Form 10-K for fiscal 2025, citing the need for more time to complete the classification of inter-company transactions and balances. The company expects to file the annual report within the 15‑day grace period.
AirSculpt released preliminary, unaudited results showing fiscal 2025 revenue of $151.8 million and fourth quarter 2025 revenue of $33.4 million, with same-store revenue down about 16% in the quarter but improving to down single digits in December. For first quarter 2026, it expects revenue of $38.5–$39.5 million, implying roughly flat same-store revenue at the midpoint after positive comparable sales in February. As of March 13, 2026, cash was $13.0 million and debt was $46.0 million, which the company characterizes as a strong balance sheet and enhanced liquidity.
Aaron Rollins filed a Schedule 13D reporting beneficial ownership of 14,721,062 shares of Airsculpt Technologies, Inc., representing 23.6% of its common stock. He holds sole voting and dispositive power over these shares, reflecting his role as founder and former CEO and Executive Chairman.
Rollins states that his stake comes from equity compensation for his executive roles and from personal open-market purchases, including 152,118 shares bought for about $473,837.49, excluding commissions. He is actively evaluating strategic alternatives for his investment, which may include buying more shares, selling shares, seeking board representation, proposing strategic or change-of-control transactions, or advocating changes to strategy, governance, management, or capital allocation. He has not traded in the past 60 days and notes no contracts or arrangements relating to the issuer’s securities.
Airsculpt Technologies, Inc. major shareholder Jorey Chernett reported an open-market purchase of 88,000 shares of Common Stock at a weighted average price of $2.15 per share. The shares were bought in multiple trades between $2.11 and $2.25 per share. Following this transaction, Chernett directly owns 6,486,211 shares, so the new purchase increases an already large position by a relatively small proportion.
Airsculpt Technologies, Inc. major holder Jorey Chernett bought additional shares of the company. On this Form 4, Chernett reported an open-market purchase of 45,600 shares of common stock at a weighted average price of about $2.00 per share, increasing his direct holdings to 6,398,211 shares.